News
Media
PodcastsCase Based Peer PerspectivesInsightsInvestigator PerspectivesMedical World NewsPeer ExchangePeers & PerspectivesVideos
Conferences
Conference CoverageConference Listing
Publications
Contemporary OB/GYN® JournalDigital Supplements
More
CME/CE
Resources
Physician Fact SheetsInteractive ToolsSponsored MediaSponsored ResourcesSupplements and Featured Publications
About
Partnerships

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • About
  • Partnerships
  • Breast Health
  • COVID-19
  • Cervical Health
  • Contraception
  • Curbside Consults
  • Dermatology
  • Drug Pipeline News
  • Endometriosis
  • Genetic Testing
  • Gynecology
    • Gynecologic Oncology
  • Imaging
    • Fetal Imaging
    • Abnormal Obstetrical Ultrasound
    • MRI
    • Ultrasound
    • Women's Imaging
    • Breast Imaging
    • Women's Ultrasound
  • Infertility
  • LARC
  • Legally Speaking
  • Life Transitions
  • Malpractice
  • Menopause
  • Mental Health
  • Noninvasive Prenatal Testing
  • Obstetrics
  • Opinion
  • Osteoporosis
  • Pediatrics
  • Practice Management
  • Pregnancy and Birth
  • Sexual Health
  • Sexually Transmitted Infections
  • Surgery
  • Technology
  • Urology
  • Uterine Fibroids
  • Vulvovaginal Disease
  • Well Woman
Advertisement

George Saade, MD

Advertisement

Articles by George Saade, MD

Society for Maternal-Fetal Medicine Consult Series #51: Thromboembolism prophylaxis for cesarean delivery

ByThe Society for Maternal-Fetal Medicine (SMFM),Luis D. Pacheco, MD,George Saade, MD,Torri D. Metz, MD
October 5th 2020

The risk of venous thromboembolism is particularly high during the postpartum period and especially following cesarean delivery.

Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on Contemporary OB/GYN

    1

    Nonhormonal therapies transform menopause care in 2025

    2

    FDA clears FemVue Controlled for in-office tubal assessment

    3

    Contemporary OB/GYN week in review: FemVue clearance, flibanserin approval, and more

    4

    GSK, Spero Therapeutics resubmits NDA for tebipenem HBr as oral option for complicated urinary tract infections

    5

    Multidisciplinary initiative boosts iron deficiency screening in pregnancy

    • Advertise
    • Contact Us
    • Job Board
    • Terms of Use
    • Privacy Policy
    • Do Not Sell My Personal Information
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    609-716-7777

    Brand Logo

    © 2025 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us